These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38157159)

  • 1. Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature.
    Mousavi-Aghdas SA; Farashi E; Naderi N
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):19-37. PubMed ID: 38157159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes.
    Sumneang N; Siri-Angkul N; Kumfu S; Chattipakorn SC; Chattipakorn N
    Arch Biochem Biophys; 2020 Feb; 680():108241. PubMed ID: 31891670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial Iron Deficiency and Mitochondrial Dysfunction in Advanced Heart Failure in Humans.
    Zhang H; Jamieson KL; Grenier J; Nikhanj A; Tang Z; Wang F; Wang S; Seidman JG; Seidman CE; Thompson R; Seubert JM; Oudit GY
    J Am Heart Assoc; 2022 Jun; 11(11):e022853. PubMed ID: 35656974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral deferiprone for iron chelation in people with thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Chowdhury O; Gooding S; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004839. PubMed ID: 23966105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mitochondrial and systemic iron levels in heart failure pathology.
    Lupu M; Tudor DV; Filip GA
    Heart Fail Rev; 2019 Sep; 24(5):647-659. PubMed ID: 31016425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives.
    Corradi F; Masini G; Bucciarelli T; De Caterina R
    Cardiovasc Res; 2023 Nov; 119(14):2405-2420. PubMed ID: 37722377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress induces mitochondrial iron overload and ferroptotic cell death.
    Chen Y; Guo X; Zeng Y; Mo X; Hong S; He H; Li J; Fatima S; Liu Q
    Sci Rep; 2023 Sep; 13(1):15515. PubMed ID: 37726294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Sawicki KT; De Jesus A; Ardehali H
    Circ Res; 2023 Feb; 132(3):379-396. PubMed ID: 36730380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
    Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation alleviates multiple pathophysiological pathways in a rat model of cardiac pressure overload.
    Lupu M; Coada CA; Tudor DV; Baldea I; Florea A; Toma VA; Lupsor A; Moldovan R; Decea N; Filip GA
    Free Radic Biol Med; 2023 May; 200():1-10. PubMed ID: 36822542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study.
    Cilloni D; Ravera S; Calabrese C; Gaidano V; Niscola P; Balleari E; Gallo D; Petiti J; Signorino E; Rosso V; Panuzzo C; Sabatini F; Andreani G; Dragani M; Finelli C; Poloni A; Crugnola M; Voso MT; Fenu S; Pelizzari A; Santini V; Saglio G; Podestà M; Frassoni F
    Sci Rep; 2020 Jun; 10(1):9156. PubMed ID: 32514107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of iron metabolism in heart failure: From iron deficiency to iron overload.
    Zhang H; Zhabyeyev P; Wang S; Oudit GY
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1925-1937. PubMed ID: 31109456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.
    Bultman SJ; Holley DW; G de Ridder G; Pizzo SV; Sidorova TN; Murray KT; Jensen BC; Wang Z; Bevilacqua A; Chen X; Quintana MT; Tannu M; Rosson GB; Pandya K; Willis MS
    Cardiovasc Pathol; 2016; 25(3):258-269. PubMed ID: 27039070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes.
    Zheng H; You J; Yao X; Lu Q; Guo W; Shen Y
    J Cell Mol Med; 2020 Sep; 24(18):11030-11033. PubMed ID: 32780538
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic Energy Depletion due to Iron Deficiency Impairs Dendritic Mitochondrial Motility during Hippocampal Neuron Development.
    Bastian TW; von Hohenberg WC; Georgieff MK; Lanier LM
    J Neurosci; 2019 Jan; 39(5):802-813. PubMed ID: 30523068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferiprone for the treatment of transfusional iron overload in thalassemia.
    Belmont A; Kwiatkowski JL
    Expert Rev Hematol; 2017 Jun; 10(6):493-503. PubMed ID: 28448199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks.
    Li J; Jia YC; Ding YX; Bai J; Cao F; Li F
    Int J Biol Sci; 2023; 19(9):2756-2771. PubMed ID: 37324946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.